Percutaneous tumour ablation is a minimally invasive, image guided procedure which attracts a low morbidity (2%--10%) and procedure-related deaths are exceptional. As such it can be offered to patients who could not withstand more invasive procedures such as surgical resection. Complications can be divided into systemic and local, those related to the anatomical area and those specific to the ablative technique or the particular tumour type. Most ablation experience has been gained using radiofrequency in the liver for metastases or hepatocellular carcinoma. Newer applications include ablation of inoperable lung primary or metastatic disease and renal cell carcinoma. The most common complications are haemorrhage, super-added infection or collateral damage. Tumour dissemination, whilst a theoretical risk, is very unusual.

Author

A R Gillams

Contact Details

Corresponding address:
Dr A Gillams,
Department of Medical Imaging,
The Middlesex Hospital,
Mortimer Street, London, W1T 3AA,
UK.

Reference

ICIS Cancer Imaging Volume 5 Issue 1
DOI: 10.1102/1470-7330.2005.0017

Date Posted

21 September 2005

Screen PDF

Size

236.62 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	3 seconds
64 Kb/s (ISDN):	29 seconds
33.3 Kb/s (Typical Modem):	56 seconds

Print PDF

Size

464.35 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	7 seconds
64 Kb/s (ISDN):	58 seconds
33.3 Kb/s (Typical Modem):	1 minute 51 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.